2Lensen R, Rosendaal F, Vandenbroucke J,et al. Factor V lei- den: the venous thrombotic risk in thrombophilic families [J]. Br J Haematol,2000,110(4) :939 - 945.
3Castaman G, Tosetto A,'Ruggeri R, et al. Pseudohomozygosi- ty for activated protein C resistance is a risk factor for venousthrombosis[J]. Br J Haematol, 1999,106(1) :232 - 236.
4O'Donnell J, Mumford AD, Manning RA, et al. Elevation of F：:C in venous thromboembolism is persistent and inde- pendent of the acute phase reaction[J]. Thromb Haemost, 2000,83(1) :10 - 13.
5Kyrle P, Minar E, Hirschl M, et al. High plasma levels of fac- tor "： and the risk of recurrent venous thromboembolism[J]. N Engl J Med,2000,343(7) ,457 - 462.
6Soria SM, Almasy L, Souto JC, et al. Linkage anglysis demon- strates that the prothrombin G20210A mutation jointly influ- ences plasma prothrombin levels and risk of throbosis[J]. Blood,2000,95(9) :2780 - 2785.
7Margaglione M, Braneaceio V, Lucia DD, et al. Inherited thro- mbopbilic risk factors and venous thromboembolism: distint role in peripheral deep venous thrombosis and pulmonary em- bolism[J]. Chest, 2000,118 (5) : 1405 - 1411.
10Hansson PO,Welin L,Tibblin G,et al. Deep vein thrombosis and pulmonary embolism in the general population." The Study of Men Born in 1913" [J]. Arch Intern Med, 1997,157: 1665 - 1670.
